Abstract
Fatigue is considered to be one of the most common and disabling symptoms among individuals with multiple sclerosis (MS). The aim of this study is to investigate if an intensive, short-term inpatient rehabilitation program is able to improve fatigue in MS, and if fatigue is able to negatively influence the clinical and functional outcome of rehabilitation in MS. One-hundred eighty six consecutively recruited MS patients underwent an intensive, short-term inpatient rehabilitation program. Sixty-four of them were selected for this study according to our inclusion criteria and compared to a control group of 22 MS patients who did not follow a rehabilitation program. We measured fatigue symptoms with the Fatigue Severity Scale (FSS) before and after rehabilitation, and classified patients into fatigued (FMS) in the case of an FSS score ≥36 and into non-fatigued MS (NFMS) in the case of an FSS <36. Expanded Disability Status Scale (EDSS) and Functional Independence Measure (FIM) were used as clinical outcome measures of the efficacy of the rehabilitation program. In our sample, an intensive, short-term rehabilitation treatment is able to determine a significant reduction of fatigue symptoms compared to untreated MS patients (p < 0.0001); however, the presence of fatigue at the beginning of the rehab program seems not to have any impact on the clinical and functional outcome of rehabilitation. An intensive inpatient rehabilitation trial decreases symptom of fatigue in MS patients; furthermore fatigue seems not to modify the amelioration of disability and impairment determined by a rehabilitation program.
Similar content being viewed by others
References
Multiple Sclerosis Council for Clinical Practice Guidelines (1998) Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Paralyzed Veterans of America, Washington, DC
Iriarte J, Subira ML, Castro P (2000) Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors. Mult Scler 6:124–130
Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ (1994) The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 21:9–14
Freal JE, Kraft GH, Coryell JK (1984) Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 65:135–138
Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Fatigue in multiple sclerosis. Arch Neurol 45:435–437
Kos D, Kerckhofs E, Nagels G, D’hooghe MB, Ilsbroukx S (2008) Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair 22:91–100
Leocani L, Colombo B, Comi G (2008) Physiopathology of fatigue in multiple sclerosis. Neurol Sci 29:241–243
Ponichtera-Mulcare J (1992) Exercise and multiple sclerosis. Med Sci Sports Exerc 25:451–465
Sutherland G, Andersen MB (2001) Exercise and multiple sclerosis: physiological, psychological, and quality of life issues. J Sports Med Phys Fit 41:421–432
Bergamaschi R, Romani A, Versino M, Poli R, Cosi V (1997) Clinical aspects of fatigue in multiple sclerosis. Funct Neurol 12:247–251
Pittion-Vouyovitch S, Debouverie M, Guillemin F, Vandenberghe N, Anxionnat R, Vespignani H (2006) Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci 243:39–45
Vercoulen JH, Hommes OR, Swanink CM, Jongen PJ, Fennis JF, Galama JM et al (1996) The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol 53:642–649
Vercoulen JH, Swanink CM, Galama JM, Fennis JF, Jongen PJ, Hommes OR et al (1998) The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 45:507–517
Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K et al (2000) Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 6:181–185
Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L et al (1995) Fatigue therapy in multiple sclerosis: results of a doubleblind, randomised, parallel trial of amantadine, emoline and placebo. Neurology 45:1956–1961
Mohr DC, Hart SL, Goldberg A (2003) Effects of treatment for depression on fatigue in multiple sclerosis. Psychosom Med 65:542–547
Oken BS, Kishiyama S, Zajdel D, Bourdette D, Carlsen J, Haas M et al (2004) Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 62:2058–2064
Mathiowetz V, Finlayson ML, Matuska KM, Yun Chen H, Luo P (2005) Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Mult Scler 11:592–601
Patti F, Ciancio MR, Reggio E, Lopes R, Palermo F, Cacopardo M et al (2002) The impact of outpatient rehabilitation on quality of life in multiple sclerosis. J Neurol 249:1027–1033
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
Tombaugh TN (2006) A comprehensive review of the Paced Auditory Serial Addition Test (PASAT). Arch Clin Neuropsychol 21:53–76
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452
Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907–911
Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123
Sharrack B, Hughes RA, Soudain S, Dunn G (1999) The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 122:141–159
Cutter G, Baier M, Rudick R, Cookfair D et al (1999) Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 122:871–882
Colombo B, Martinelli Boneschi F, Rossi P, Rovaris M, Maderna L, Filippi F et al (2000) MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue. J Neurol 247:506–509
Leocani L, Colombo B, Magnani G, Martinelli-Boneschi F, Cursi M, Rossi P et al (2001) Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement—EEG evidence. Neuroimage 13:1186–1192
Codella M, Rocca MA, Colombo B, Rossi P, Comi G, Filippi M (2002) A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue. J Neurol 249:535–537
Lapierre Y, Hum S (2007) Treating fatigue. Int MS J 14:64–71
Lee D, Newell R, Ziegler L, Topping A (2008) Treatment of fatigue in multiple sclerosis: a systematic review of the literature. Int J Nurs Pract 14:81–93
Romberg A, Ruutiainen J, Puukka P, Poikkeus L (2008) Fatigue in multiple sclerosis patients during inpatient rehabilitation. Disabil Rehabil 30:1480–1485
Lange R, Volkmer M, Heesen C, Liepert J (2009) Modafinil effects in multiple sclerosis patients with fatigue. J Neurol 256(9):645–650
Smith C, Hale H, Olson K, Schneiders A (2009) How does exercise influence fatigue in people with multiple sclerosis? Disabil Rehabil 31(9):685–692
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Judica, E., Martinelli Boneschi, F., Ungaro, D. et al. Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis. J Neurol 258, 835–839 (2011). https://doi.org/10.1007/s00415-010-5851-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-010-5851-6